Recently, a delegation from Dalian Jinpu New Area, led by Zhao Yupeng, Member of the Standing Committee of the Party Working Committee and Minister of the United Front Work Department; Lin Hai, Chairman of the Federation of Industry and Commerce and President of the General Chamber of Commerce; Tang Bojie, Deputy Director of the Investment Promotion Bureau of Dalian Puwan Economic Zone; Lv Xianjia, Section Chief of the Domestic Investment Section of the Commerce Bureau of Dalian Jinpu New Area; and Ning Wei, Specialist at the Investment Promotion Bureau of Dalian Puwan Economic Zone, visited Shenzhen Cell Valley for inspection and research. They were warmly received by Shi Yuanyuan, Chairman and Professor; Wang Jianxun, Chief Scientist and Professor; Tang Xiaomeng, Deputy General Manager; Tang Hui, Head of the Commerce Department; and Jia Haitao, Medical Expert at the Precision Medicine Department, who also participated in a symposium.

Accompanied by Professor Shi Yuanyuan, the visiting leaders toured the Smart Exhibition Hall and the GMP Production Workshop of Shenzhen Cell Valley. They gained a preliminary understanding of the company's development history, current construction status, strategic planning, and core products.

During the symposium, Professor Shi Yuanyuan warmly welcomed the leaders and provided an in-depth introduction to Shenzhen Cell Valley's strategic layout in the field of cell therapy. He emphasized that the company's deep strategic cooperation with authoritative institutions—such as the Cell Therapy Transformation Research Institute co-established with Shenzhen Hospital of Southern Medical University and the National Engineering Research Center for Cell Industry Key Generic Technologies—aims to create a full-cycle service platform covering vector design, cell production and preparation, clinical application, and registration services. This platform is dedicated to providing comprehensive and powerful support for the innovative development of the cell therapy industry. Professor Shi Yuanyuan also noted that, thanks to the strong support of the Qianhai Free Trade Zone government, Deep Harbour Cell Valley, a wholly-owned subsidiary of Shenzhen Cell Valley, has successfully settled in the Qianhai Dream Workshop and is expected to be fully operational within two months. Deep Harbour Cell Valley will be positioned as the core headquarters for the Cell Valley Group's international business and medical services, focusing on providing high-end cell and gene therapy services to B2B and B2C clients in the Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, and the Americas, aiming to further enhance the company's influence in the global market.

At the symposium, Minister Zhao Yupeng introduced that Dalian Jinpu New Area, as the first national-level new area in Northeast China and a top 100 industrial district nationwide, shoulders important strategic missions. The strategic positioning of the new area is "One Base, One Pole, and Three Zones"—a strategic highland for open cooperation facing Northeast Asia, particularly the Japanese and South Korean markets; an important growth pole leading the comprehensive revitalization of the Northeast region; and a pilot zone for transforming development models in old industrial bases, a demonstration zone for institutional innovation and independent innovation, and a pioneer zone for new urbanization and urban-rural coordination. With its fully functional highland for opening up, a modern industrial base with advantageous clusters, a major transportation hub with access in all directions, and fertile ground for cultural convergence, Jinpu New Area possesses unique advantages for all-round development.

The purpose of this visit to Shenzhen Cell Valley was to conduct on-site research and engage in deeper communication. The delegation expressed hope to introduce Shenzhen Cell Valley's advanced industrial technology and collaborate with high-quality hospitals in the district, such as the Affiliated Hospital of Dalian University of Technology and the Affiliated Hospital of Dalian Medical University, to build a cell therapy highland in Northeast Asia. They aim to work together to further develop both regions in the field of high-tech industries and facilitate the synergistic progress of the regional economy.